Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Current Price	$174.30
Prev Close	$176.06
Open	$174.70
Dividend Yield	0.00%
50-Day Moving Average	$186.25
Beta	0.53
Avg. Volume	7.36M
PE Ratio	6.85

52-Week High	$217.25
52-Week Low	$115.03
Market Capitalization	$72.74B
EPS	$27.65
Price to Book	4.07
Revenue Per Employee	$7.86M
Enterprise Value/EBITDA	3.10

MRNA Moderna Inc

About

Feed

Fundamentals

News